Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Frontal Hyperhidrosis
NCT07561580Recruiting
- Sponsor
- Tishreen University
- Start
- Nov 2025
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in primary focal hyperhidrosis (PFH), sponsored by Tishreen University. Primary endpoints: Hyperhidrosis Disease Severity Scale at 1 month and Hyperhidrotic area assessed by Minor's iodine-starch test at 1 month. Started Nov 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
primary focal hyperhidrosis (PFH)
Beyond the preview
Go deeper on NCT07561580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07561580.